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ABSTRACT
We present the case of a 33-year-old woman who was diagnosed with disseminated Kaposi’s sarcoma and HIV infection. The patient 
improved on highly active antiretroviral therapy (HAART), however, 9 days into treatment, she became febrile and dyspnoeic and developed 
tender cervical and axillary lymphadenopathy. Despite treatment for suspected sepsis and immune reconstitution, she died in intensive 
care. Lymph node biopsies revealed coexistent Castleman’s disease and Kaposi’s sarcoma. Initiation of HAART can be rarely associated with 
unmasking and rapid progression of Castleman’s disease, a phenomenon called immune reconstitution. Urgent investigation and treatment 
with agents such as steroids and cytotoxic drugs can be life-saving.
LEARNING POINTS
•	 Multicentric	Castleman’s	disease	tends	to	present	with	lymphadenopathy	and	various	non-specific	symptoms,	especially	in	the	context	
of HIV infection.
•	 HAART	can	rarely	unmask	symptoms	of	multicentric	Castleman’s	disease,	a	phenomenon	called	immune	reconstitution	inflammatory	
syndrome.
• Since multicentric Castleman’s disease can be rapidly fatal in the context of HIV infection, lymph node biopsy should be undertaken early 
so that treatment can be started urgently.
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INTRODUCTION
Lymphadenopathy in the context of Kaposi’s sarcoma and HIV infection can be due to numerous causes, including metastatic Kaposi’s 
sarcoma and opportunistic infections. However, it should alert the clinician to the possibility of coexistent Castleman’s disease, a rare 
lymphoproliferative disorder which shares the same viral aetiology as Kaposi’s sarcoma[1]. We report a case of an HIV-positive patient with 
Kaposi’s sarcoma who developed rapidly progressive Castleman’s disease shortly after initiation of highly active antiretroviral therapy (HAART).
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CASE PRESENTATION
A 33-year-old female Somali refugee presented to hospital with a 3-month history of fever, productive cough, haemoptysis, night sweats, 
weight loss and a skin eruption. On examination, there were several violaceous nodules and plaques up to 2.5 cm in diameter, suggestive of 
Kaposi’s sarcoma, on the trunk (Fig. 1), upper limbs and oral mucosa as well as bilateral diffuse crepitations in the chest. There was no clinical 
evidence of lymphadenopathy at presentation.
The patient was admitted to hospital where an HIV antibody test, serial sputa test for acid-fast bacilli and blood culture tests, including 
Figure 1: Violaceous nodules and plaques suggestive of Kaposi’s sarcoma on 
the back of the patient.
cultures for mycobacteria, were carried out. A chest X-ray revealed diffuse reticulonodular shadowing. A computed tomography (CT) 
scan of the thorax was suggestive of disseminated pulmonary Kaposi’s sarcoma with axillary and retroperitoneal lymphadenopathy. Serial 
sputa were negative for acid-fast bacilli. Empiric treatment for Pneumocystis jirovecii pneumonia was started with a combination of oral co-
trimoxazole	and	prednisolone.	On	Day	6,	when	it	was	confirmed	that	the	patient	was	HIV	positive,	with	a	CD4	count	of	247/mm3, HAART 
was initiated using a combination of lopinavir/ritonavir and lamivudine/zidovudine. On treatment, the patient’s fever and respiratory 
symptoms	improved.	Clinically,	some	regression	of	the	cutaneous	nodules	and	plaques	was	noted.	However,	on	Day	14,	the	patient	again	
developed high fever, night sweats, lateral neck pain, nausea and vomiting. She became progressively pancytopenic and hypoalbuminaemic. 
Her	erythrocyte	sedimentation	rate	(ESR)	rose	to	95	mm/h	and	C-reactive	protein	(CRP)	to	144	mg/dl	from	previously	normal	levels	prior	
to	initiation	of	HAART.	On	examination,	multiple	tender,	firm	cervical	and	axillary	lymph	nodes	were	palpable.	Skin	and	lymph	node	biopsies	
were	organized	and	a	chest	X-ray	showed	that	infiltrates	were	now	much	more	diffuse.	The	patient	was	treated	empirically	with	intravenous	
broad-spectrum	antibiotics	and	intravenous	hydrocortisone	for	possible	immune	reconstitution	inflammatory	syndrome	(IRIS)	and	sepsis.	
However, she continued to deteriorate and on Day 20 was admitted to the Intensive Care Unit with respiratory failure and died within a few 
hours.
Blood cultures did not reveal microbial growth. The skin biopsy demonstrated a spindle cell proliferation arranged in fascicles forming cleft-
like	spaces	that	contained	erythrocytes	 infiltrating	the	dermis.	Haemosiderin	deposition	was	also	observed.	The	 lymph	nodes	showed	a	
similar spindle cell proliferation, and follicular hyperplasia with a narrow mantle zone surrounded by sheets of plasma cells. The germinal 
centres contained dendritic and endothelial cells and appeared partly hyalinized (Fig. 2). Immunohistochemistry revealed diffuse expression 
of CD31 and HHV8 by the spindle cells in the skin and lymph nodes. HHV8 was also expressed in the abnormal germinal centres. These 
findings	were	compatible	with	Kaposi’s	sarcoma	affecting	the	skin	and	lymph	nodes;	with	the	multicentric	variant	of	the	plasma	cell	type	of	
Castleman’s disease within lymph nodes (Fig. 3). The fact that Castleman’s disease progressed so rapidly and presented after commencing 
HAART is compatible with IRIS.
DISCUSSION
Figure 2: H&E ×100: The photomicrograph shows the follicular hyperplasia, 
narrow mantle zone and sheets of plasma cells from a lymph node affected by 
Castleman’s disease. 
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Kaposi’s	sarcoma	is	a	vascular	spindle	cell	tumour	that	is	an	AIDS-defining	illness.	The	association	between	Kaposi’s	sarcoma	and	human	
herpesvirus-8	was	first	reported	in	1994	and	most	of	the	spindle	and	endothelial	cells	within	Kaposi’s	sarcoma	are	infected	with	HHV-8[1]. 
Castleman’s disease is a rare lymphoproliferative disorder in which HHV-8 infection also plays an important role in the aetiology[2]. The 
unicentric form of the disease is often discovered incidentally as a mediastinal mass on imaging and accounts for around 90% of cases[2]. 
The multicentric variant tends to feature constitutional symptoms including high fevers, night sweats, fatigue, anorexia and weight loss. 
Lymphadenopathy is nearly universal and hepatosplenomegaly is present in around half of the cases[2]. Common laboratory abnormalities 
include	anaemia,	thrombocytopenia,	elevated	ESR	and	CRP,	deranged	liver	profile,	hypoalbuminaemia	and	renal	dysfunction[2]. The disease 
tends	to	follow	an	aggressive	course	and	flares	can	be	fatal[2]. In addition, since the symptoms and laboratory abnormalities are very non-
specific,	the	condition	is	often	diagnosed	late	or	missed.
The coexistence of Castleman’s disease and Kaposi’s sarcoma has been reported previously since both are associated with HHV-8[2]. What 
was unusual in our patient is that the symptoms of Castleman’s disease became evident and progressed so rapidly within days of initiation of 
HAART.	This	unmasking	of	an	occult	disease	after	initiation	of	antiretroviral	therapy	is	referred	to	as	immune	reconstitution	inflammatory	
syndrome (IRIS). While it is recognised that Kaposi’s sarcoma tends to improve with HAART, data regarding the effect of HAART on 
multicentric	Castleman’s	disease	is	conflicting[2,3]. While some report successful treatment of the condition with HAART alone, others claim 
that multicentric Castleman’s disease does not regress with HAART alone[2–4].
Several treatment options have been described for multicentric Castleman’s disease, however because of the variety of clinical contexts 
and the rarity of the disease, there is no standard treatment yet. Rituximab is promising, however, it can lead to progression of Kaposi’s 
sarcoma[2]. Chemotherapeutic agents such as doxorubicin, etoposide and vinblastine may be considered when multicentric Castleman’s 
disease coexists with Kaposi’s sarcoma[2,5].
Multicentric Castleman’s disease is a rapidly progressive condition and the key to optimum management lies in early recognition of its 
clinical	features	and	relevant	investigations	to	confirm	the	diagnosis.	Patients	started	on	HAART	should	be	monitored	for	features	of	this	
disease, which may require management as a medical emergency[4].
Figure 3. A. H&E ×100: The photomicrograph shows a germinal centre with a partly hyalinized core and a narrow mantle zone surrounded 
by sheets of plasma cells in the upper left corner (Castleman’s disease) and a spindle cell infiltrate with cleft-like spaces containing 
erythrocytes (Kaposi’s sarcoma) in the lower right corner. B. HHV8 ×100: The photomicrograph shows strong nuclear positivity by both 
the spindle cells and the lymphoid cells surrounding the abnormal germinal centre.
